RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA
Clinical trials for RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bladder cancer combo trial: could adding chemo to BCG keep tumors away?
Disease control Recruiting nowThis phase 3 trial tests whether adding the chemotherapy drug gemcitabine to standard BCG therapy can better prevent high-grade bladder cancer from coming back. About 330 people with recurrent non-muscle invasive bladder cancer will receive either BCG alone or BCG plus gemcitabin…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Broccoli vs. bladder cancer: could your diet keep tumors away?
Disease control Recruiting nowThis study tests a healthy eating program that encourages people with early-stage bladder cancer to eat more cruciferous vegetables like broccoli, kale, and cabbage. These veggies contain natural compounds that may help fight cancer cells. Researchers want to see if this diet cha…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New nanoparticle therapy targets bladder cancer cells
Disease control Recruiting nowThis early-stage trial tests a new treatment called PLZ4-coated paclitaxel-loaded micelles (PPM) for people with non-muscle invasive bladder cancer that has come back or not responded to standard therapy. PPM is a nanoparticle designed to deliver chemotherapy directly to tumor ce…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC